BNET Industries
Last Fiscal Year Sales:$37.5M
- Private
- US
Dow Jones Description
BioGenex is Advancing the Pace of Predictive Medicine by providing a "Total Solution" for complete automation of cell and tissue testing. BioGenex offers a broad range of reagents, detection kits, antibodies, probes, special stains, automated staining and imaging systems to streamline and standardize cellular and molecular analysis. Our state-of-the-art automated systems are designed for high throughput at a low cost of ownership. They provide consistent, quality results with ease of use and maximum flexibility for clinical diagnostics, life science research, and drug discovery. Our customers include reference labs, hospitals, cancer treatment centers, academic medical institutions, and, pharmaceutical and biotechnology companies.
Chairman and Chief Executive Officer
Krishan L KalraNumber of Employees 174
Contact Information
4600 Norris Canyon Rd
San Ramon, California 94583
1 925 275 0550
Peer Companies
NAICS Code Surgical and Medical Instrument Manufacturing: 339112
News & Analysis
Filter by
biogenex inc. - All News and Analysis
Abbott & BioGenex Extend the Technology Co-development and Distribution Agreement for Marketing the Xmatrx® Advanced Staining Platform for the Automation of FISH, IHC and ISH Molecular Diagnostic Assays
- 2009-06-02
SAN RAMON, Calif., June 2 /PRNewswire/ -- BioGenex, a developer of innovative instruments and reagents for automated slide based staining systems for molecular diagnostics, announced today that Abbott has entered into a definitive agreement to extend the technology co-development and distribution agreement to market the XmatrxR platform...
Abbott & BioGenex Extend the Technology Co-development and Distribution Agreement for Marketing the Xmatrx(R) Advanced Staining Platform for the Automation of FISH, IHC and ISH Molecular Diagnostic Assays.
- 2009-06-02
SAN RAMON, California, June 2 /PRNewswire/ -- BioGenex, a developer of innovative instruments and reagents for automated slide based staining systems for molecular diagnostics, announced today that Abbott has entered into a definitive agreement to extend the technology co-development and distribution...
BioGenex, Ventana settle patent litigation.(BioGenex Laboratories Inc.)(Ventana Medical Systems Inc.)
- 2007-05-01
BioGenex Laboratories (San Ramon, CA) announced a settlement of patent litigation with Ventana Medical Systems, ending the dispute between the two companies. As part of the settlement, the parties agreed to cross license several of their patents. BioGenex is licensed to utilize Ventana patented methods...
BioGenex Labs, San Ramon, CA, July 27
- 2006-08-01
During an FDA investigation of BioGenex conducted from Feb. 1 through March 9, the agency determined that the manufacturer of pathology related stains, antibodies and in vitro diagnostic test kits was not in conformance with current GMP requirements of QS regulations for medical devices. Significant deviations included, but were not...
QS failures lead to warning letter for BioGenex
- 2006-08-01
During an FDA investigation of BioGenex Labs, San Ramon, CA, conducted from Feb. 1 through March 9, the agency determined that the manufacturer of pathology related stains, antibodies and in vitro diagnostic test kits was not in conformance with current GMP requirements of QS regulations for medical devices. Significant deviations...
BioGenex wins staining system patent suit against Ventana.
- 2005-10-01
BioGenex (San Ramon, CA) has emerged victorious after more than two-and-a-half years of litigation in federal court against Ventana Medical Systems . The United States District Court for the District of Arizona recently entered the ruling in favor of BioGenex in a patent infringement litigation between...
BioGenex obtains favorable patent ruling against Ventana.
- 2005-09-01
BioGenex Laboratories, Inc. (San Ramon, CA) received a favorable ruling in its patent infringement litigation against Ventana Medical Systems . The ruling, known as a Markman Ruling, limits the scope of Ventana's patent for automated staining. Judge Raner C. Collins of the United States...
Ventana Obtains Summary Judgment in Biogenex Litigation
- 2005-02-25
Ventana Medical Systems, Inc. (NASDAQ: VMSI), announced today the U.S. District Court for the Northern District of California San Jose Division has issued summary judgment rulings in favor of Ventana in the BioGenex v. Ventana litigation. Ventana was successful in obtaining a judgment of noninfringement of BioGenex' U.S. Patent...
Abbott and BioGenex In Market Agreement.
- 2004-11-01
Abbott (Abbott Park, IL) and BioGenex Laboratories (San Ramon, CA) have agreed to distribute and market a new system that will fully automate molecular diagnostic tests that employ Abbott's Fluorescence in situ Hybridization FISH technology. The system is designed to automate the assay steps required to...
California Business Exec Chosen for China Trade Mission; BioGenex Laboratories, Inc. Part of U.S. Chamber of Commerce Delegation
- 2002-09-16
WASHINGTON, Sept. 16 /U.S. Newswire/ -- The United States Chamber of Commerce has selected Satya Kalra, Co-Founder and Board Member of BioGenex Laboratories, Inc., as one of 12 business delegates for a trade and investment trip to China, September 20-30. The business delegates will meet with Chinese political leaders...
- 1
- 2
Decision Makers
| Name (plus bio) | Position |
|---|---|
| David Sheldon | Chief Financial Officer |
| Jintao Chen | Chief Operating Officer |
| Carl Kunkleman | Vice President, Marketing and North America Sales |
| V V Vidya Sagar | General Manager, Engineering |
| George Su | Director of Operations |
| John Young | Director, North American Sales |
| Sampath Gupta | Director, Legal Affairs |
| Jerome Loew | |
| Massimo Loda | |
| Hank Pietraszek | Director |
| Raymond Cohen | Director |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Krishan L Kalra | Chairman and Chief Executive Officer |
| Organization | Position | Status |
|---|---|---|
| Biogenex, Inc. | Chairman and Chief Executive Officer | Current |
| Organization | Position | Status |
|---|---|---|
| Biogenex, Inc. | Chief Financial Officer | Current |
| Biogenex, Inc. | Plant Manager | Current |
| Organization | Position | Status |
|---|---|---|
| Biogenex, Inc. | Chief Operating Officer | Current |
| Biogenex, Inc. | Vice President of Quality Assurance | Current |
| Organization | Position | Status |
|---|---|---|
| Biogenex, Inc. | Vice President, Marketing and North America Sales | Current |
| Organization | Position | Status |
|---|---|---|
| Biogenex, Inc. | General Manager, Engineering | Current |
| Organization | Position | Status |
|---|---|---|
| Biogenex, Inc. | Director of Operations | Current |
| Organization | Position | Status |
|---|---|---|
| Biogenex, Inc. | Director, North American Sales | Current |
| Biogenex, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Biogenex, Inc. | Director, Legal Affairs | Current |
| Biogenex, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Biogenex, Inc. | Current | |
| University of California, Los Angeles | Chief of Surgical Pathology | Former |
| University of Michigan | Professor of Pathology | Former |
| Organization | Position | Status |
|---|---|---|
| Biogenex, Inc. | Current | |
| Southern California University | Associate Dean | Former |
| Organization | Position | Status |
|---|---|---|
| E-Z Event | Chairman | Current |
| Biogenex, Inc. | Director | Current |
| Biostar, Inc. | Chief Executive Officer | Former |
| Biostar, Inc. | President | Former |
Raymond Cohen joined the Board in May 2006. Mr. Cohen currently serves as Chief Executive Officer of Laguna Hills, CA-based Symphony Medical, Inc., a venture capital backed privately-held developer of biologic solutions for the treatment of cardiac conduction abnormalities. Mr. Cohen is also a director of Cardiac Science Corporation (NASDAQ: CSCX), where he served as Chief Executive Officer for nine years, and as Chairman from September 2005 through October 2006. Mr. Cohen also serves as a member of the Board of Directors of Syncroness, Inc., a privately-held contract engineering and product development firm based in Westminster, CO. He is a member of the Advisory Board for the College of Osteopathic Medicine, Western University of Health Sciences in Pomona, CA.
| Organization | Position | Status |
|---|---|---|
| Laguna Hills | Chief Executive Officer | Current |
| Cardiac Science Corporation | Chairman | Current |
| Biolife Solutions, Inc. | Chair Audit & Finance Committee, Member Compensation Committee | Current |
| Biogenex, Inc. | Director | Current |
| Cardiac Science Corporation | Director | Current |
| Biolife Solutions, Inc. | Board of Directors | Current |
| Burdick | Director | Current |
| CardioGenesis Corporation | Board of Directors | Current |
| Symphony Medical, Inc. | Chief Executive Officer | Former |
| Symphony Medical, Inc. | Director | Former |
Industry Transcripts by Seeking Alpha
-
Synergetics USA, Inc. F1Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 16, 2009about SURG
-
Cantel Medical Corp. F1Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 09, 2009about CMN
-
The Cooper Companies, Inc. F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 08, 2009about COO
-
Medtronic Inc. F2Q10 (Qtr End 10/30/09) Earnings Call Transcript
on Nov 24, 2009about MDT
-
ZOLL Medical Corporation F4Q09 (Qtr End 27/09/09) Earnings Call Transcript
on Nov 11, 2009about ZOLL
Glass Door
Health Care Industry Companies
| Company | Employer Rating |
| Kaiser Permanente |  |
| Boston Scientific |  |
| WellPoint | |
| UnitedHealth Group |  |
| CIGNA | |
IndustryTop Rated
Presented by American Express